Sai Parenterals, via SP Analytics, to acquire majority stake in Bion Therapeutics India in an all-cash deal, adding 16 brands and a 12-state network. Sai Parenterals will acquire a majority stake in Bion Therapeutics India through its wholly owned subsidiary SP Analytics. Sai Parenterals' board approved acquiring a majority stake in Bion Therapeutics (India) Private Limited via wholly owned subsidiary SP Analytics Private Limited.